185 related articles for article (PubMed ID: 23428477)
1. Similarity between segments in protein conformational epitopes and MHC II peptides.
Li G; Wu D; Wang S; Sun J; Xu D; Cao Z
Int J Comput Biol Drug Des; 2013; 6(1-2):107-18. PubMed ID: 23428477
[TBL] [Abstract][Full Text] [Related]
2. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships.
Hattotuwagama CK; Doytchinova IA; Flower DR
Methods Mol Biol; 2007; 409():227-45. PubMed ID: 18450004
[TBL] [Abstract][Full Text] [Related]
3. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
[TBL] [Abstract][Full Text] [Related]
4. Structure of peptides associated with class I and class II MHC molecules.
Engelhard VH
Annu Rev Immunol; 1994; 12():181-207. PubMed ID: 7516668
[TBL] [Abstract][Full Text] [Related]
5. Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites.
Rajnavölgyi E; Horváth A; Gogolák P; Tóth GK; Fazekas G; Fridkin M; Pecht I
Eur J Immunol; 1997 Dec; 27(12):3105-14. PubMed ID: 9464794
[TBL] [Abstract][Full Text] [Related]
6. A practical guide to structure-based prediction of MHC-binding peptides.
Ranganathan S; Tong JC
Methods Mol Biol; 2007; 409():301-8. PubMed ID: 18450010
[TBL] [Abstract][Full Text] [Related]
7. Conformational isomers of a peptide-class II major histocompatibility complex.
Lovitch SB; Unanue ER
Immunol Rev; 2005 Oct; 207():293-313. PubMed ID: 16181344
[TBL] [Abstract][Full Text] [Related]
8. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
Dang LH; Lien LL; Benacerraf B; Rock KL
J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
[TBL] [Abstract][Full Text] [Related]
9. In silico prediction of peptide-MHC binding affinity using SVRMHC.
Liu W; Wan J; Meng X; Flower DR; Li T
Methods Mol Biol; 2007; 409():283-91. PubMed ID: 18450008
[TBL] [Abstract][Full Text] [Related]
10. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
Svensson M; Pfeifer J; Stockinger B; Wick MJ
Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
[TBL] [Abstract][Full Text] [Related]
11. A study of complexes of class II invariant chain peptide: major histocompatibility complex class II molecules using a new complex-specific monoclonal antibody.
Eastman S; Deftos M; DeRoos PC; Hsu DH; Teyton L; Braunstein NS; Hackett CJ; Rudensky A
Eur J Immunol; 1996 Feb; 26(2):385-93. PubMed ID: 8617308
[TBL] [Abstract][Full Text] [Related]
12. Role of APC in the selection of immunodominant T cell epitopes.
Ma C; Whiteley PE; Cameron PM; Freed DC; Pressey A; Chen SL; Garni-Wagner B; Fang C; Zaller DM; Wicker LS; Blum JS
J Immunol; 1999 Dec; 163(12):6413-23. PubMed ID: 10586031
[TBL] [Abstract][Full Text] [Related]
13. Peptide length-based prediction of peptide-MHC class II binding.
Chang ST; Ghosh D; Kirschner DE; Linderman JJ
Bioinformatics; 2006 Nov; 22(22):2761-7. PubMed ID: 17000752
[TBL] [Abstract][Full Text] [Related]
14. EpiDOCK: a molecular docking-based tool for MHC class II binding prediction.
Atanasova M; Patronov A; Dimitrov I; Flower DR; Doytchinova I
Protein Eng Des Sel; 2013 Oct; 26(10):631-4. PubMed ID: 23661105
[TBL] [Abstract][Full Text] [Related]
15. Structural properties of MHC class II ligands, implications for the prediction of MHC class II epitopes.
Jørgensen KW; Buus S; Nielsen M
PLoS One; 2010 Dec; 5(12):e15877. PubMed ID: 21209859
[TBL] [Abstract][Full Text] [Related]
16. Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach.
Nielsen M; Lundegaard C; Worning P; Hvid CS; Lamberth K; Buus S; Brunak S; Lund O
Bioinformatics; 2004 Jun; 20(9):1388-97. PubMed ID: 14962912
[TBL] [Abstract][Full Text] [Related]
17. Modeling the structure of bound peptide ligands to major histocompatibility complex.
Tong JC; Tan TW; Ranganathan S
Protein Sci; 2004 Sep; 13(9):2523-32. PubMed ID: 15322290
[TBL] [Abstract][Full Text] [Related]
18. Predicting the binding affinity of MHC class II peptides.
Altiparmak F; Akalin A; Ferhatosmanoglu H
Comput Syst Bioinformatics Conf; 2006; ():331-4. PubMed ID: 17369651
[TBL] [Abstract][Full Text] [Related]
19. Invariant chain peptides enhancing or inhibiting the presentation of antigenic peptides by major histocompatibility complex class II molecules.
Adams S; Humphreys RE
Eur J Immunol; 1995 Jun; 25(6):1693-702. PubMed ID: 7614997
[TBL] [Abstract][Full Text] [Related]
20. Class II HLA-peptide binding prediction using structural principles.
Mohanapriya A; Lulu S; Kayathri R; Kangueane P
Hum Immunol; 2009 Mar; 70(3):159-69. PubMed ID: 19187794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
